TFGT
ALNY icon

TS Financial Group (TSFG)’s Alnylam Pharmaceuticals ALNY Stock Holding History

TS Financial Group (TSFG)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17
Closed -$3K – 908
2021
Q4 		$3K Sell
17
-75
-82% -$13.9K ﹤0.01% 703
2021
Q3 		$17K Buy
92
+4
+5% +$750 0.01% 453
2021
Q2 		$15K Buy
+88
New +$12.9K 0.01% 475

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TS Financial Group (TSFG)'s ALNY Position: Q1 2022 in Review

TS Financial Group (TSFG) sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2022, closing a stake of 17 shares — an estimated $3K sold.

TS Financial Group (TSFG) first reported a position in ALNY in Q2 2021 and held it in 3 quarters. The position peaked at $17K in Q3 2021. 444 funds tracked by Wall St. Rank hold ALNY as of Q1 2022.

  • TS Financial Group (TSFG) reported no remaining Alnylam Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 17 Alnylam Pharmaceuticals shares in Q1 2022, an estimated $3K.
  • TS Financial Group (TSFG) first reported a position in Alnylam Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • TS Financial Group (TSFG)'s Alnylam Pharmaceuticals position peaked at $17K in Q3 2021.
  • 444 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2022.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2022, filed 25 Apr 2022.